F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Cold Fund

Dart Ventures

www.dart.ventures · Zurich, Switzerland

“DART invests in early-stage Swiss and European teams working on breakthrough technologies that positively impact health and climate. They provide a 12-month tailored program covering strategy, culture, fundraising, and US expansion.”

Leads
Lead Tendency
01Investment Thesis

DART invests in early-stage Swiss and European teams working on breakthrough technologies that positively impact health and climate. They provide a 12-month tailored program covering strategy, culture, fundraising, and US expansion.

Exclusion Criteria

Companies not focused on health or climate impact, non-European founders, incremental rather than breakthrough technologies.

02Investment Team
SL
Sophie Lamparter
Managing Partner
PR
Priska Roesli
Partner
JK
Jasmine Kent
Team Member
CB
Cheshta Balwani
Team Member
03F4 Research Brief

DART Ventures Research

Overview

DART Ventures (also known as DART Labs) is a Zurich-based early-stage venture capital firm founded in 2018 that invests in Swiss and European founders working on breakthrough technologies in health and climate. The firm operates a unique model that combines pre-seed and seed investments with a 12-month tailored acceleration program designed to help European startups expand into the US market.

The firm maintains a dual presence with headquarters in Zurich, Switzerland and an office at swissnex San Francisco, positioning itself as a bridge between European innovation and US market opportunities. DART's mission-driven approach combines purpose and profit, focusing on founders who aim to fundamentally improve health outcomes and address climate challenges.

Investment Thesis

DART invests in early-stage Swiss and European teams developing breakthrough technologies that positively impact health and climate. The firm puts founders first through their tailored 12-month program that guides startups on strategy, culture, fundraising, and US expansion. Startups receive experienced partners and their networks as part of their extended team.

The firm believes that combining purpose and profit leads to meaningful impact. They are particularly interested in deep-tech, scientific solutions rather than incremental improvements, targeting companies that drive decarbonization, facilitate energy transition, and reduce global environmental footprint.

Stage Focus

DART focuses on pre-seed and seed stage investments. Their specialties include university spin-offs, indicating strong ties to European research institutions. The firm is designed to fund big visions early on, specifically targeting teams that need access to large markets and are tackling courageous missions.

Check Size

Specific check sizes are not publicly disclosed. Based on the firm's early-stage focus and portfolio characteristics, investments likely range in typical pre-seed/seed ranges for European VC.

Sector Focus

Health

DART invests at the convergence of consumer tech and health tech. They look for startups creating novel patient-centric hardware and software tools that provide AI-enabled, personalized, continuous, and expanded access to care beyond traditional clinical settings. Portfolio examples include fertility care (Bea Fertility), brain health therapy (BottNeuro), implantable bio-sensors (Impli), vision technology (Perivision), and continuous health monitoring (Una Health, Resmonics).

Climate

The firm invests in companies reducing environmental impact through deep-tech and breakthrough scientific solutions. Focus areas include decarbonization, energy transition, and reducing global footprint. Portfolio examples include bioplastics from organic waste (Fluidsolids), sustainable packaging (Gaeastar), fuel cells (Inergio), and cultivated meat (Orbillion Bio).

Geographic Focus

DART specifically targets Swiss and European founding teams, helping them expand into the US market. The firm is woven into both US and Swiss ecosystems, connecting the best of both. They offer US investors access to European talent pools and help European startups become global players.

Portfolio

DART's portfolio includes 15 startups with a 50% diversity factor and 1 exit. The portfolio spans:

Health Companies: Bea Fertility (at-home fertility care), BottNeuro (digital brain health), HealthCaters (organizational health), Impli (implantable bio-sensors), Perivision (AI vision care), Resmonics (lung monitoring), Testmate Health (at-home STD testing), Una Health (blood sugar tracking), VAY (motion analytics), Xsensio (on-skin bio-sensors).

Climate Companies: Fluidsolids (bioplastics), Gaeastar (sustainable cups), Inergio (mini fuel cells), Orbillion Bio (cultivated meat).

Other: Zoe (3D classroom tools).

Team and Advisors

The core team includes Sophie Lamparter (Managing Partner), Priska Roesli (Partner), Jasmine Kent, and Cheshta Balwani. DART has assembled an extensive advisory network of over 30 industry experts from organizations including Google, Meta, Stanford University, ETH Zurich, Daimler, Takeda, True Ventures, and Swisscom.

Program Model

Beyond capital, DART provides a 12-month tailored program covering:

  • Strategy development
  • Culture building
  • Fundraising support
  • US market expansion

Startups gain access to experienced partners and their networks as an extended team. The firm has demonstrated success in introducing portfolio companies to US VCs and helping secure relevant US board members.

Contact

  • Email: [email protected]
  • LinkedIn: linkedin.com/company/dartlabs
  • Twitter: @darttweeting
  • Zurich: Hardturmstr. 3, 8005 Zurich, Switzerland
  • San Francisco: swissnex, Pier 17 Suite 800, San Francisco, CA 94111
04Selected Portfolio
Biotech & Life Sciences
Impli
Climate & Sustainability
Fluidsolids
E-commerce & Marketplaces
VAY
Energy & Power
Inergio
Food & Beverage
Gaeastar
Healthcare & Digital Health
Bea Fertility·BottNeuro·HealthCaters·Resmonics·Testmate Health·Una Health·Xsensio·ZOE·Perivision
Other
Orbillion Bio
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

Portfolio company Orbillion Bio was acquired by Fork & Good to scale cultivated meat platform globally.
EXIT·agfundernews.com
OCT 2025
Participated in Perivision's CHF 2.4M seed round for AI and VR-powered eye testing.
INVESTMENT·4fdffc0b-6af4-41c6-8fa1-11f47bba26fa.filesusr.com+1
SEP 12, 2025
Arijana Walcott (Founder & Managing Partner of DART Ventures) appeared on Swisspreneur podcast EP #492 discussing fundraising from the investor's perspective.
PODCAST·swisspreneur.org
MAY 1, 2025
06Frequent co-investors
PV
Privilège Ventures
Both backed 2 of the same companies
Inergio, Xsensio
Find the investors for your round→
07Similar Firms
BV
BRAVE Venture Capital
$25K – $500K · Pre-Seed · Seed
→
UV
Upslope Ventures
$100K – $500K · Seed · Series A
→
AV
Amplifyher Ventures
$100K – $300K · Pre-Seed · Seed
→
GS
Golden Seeds
$250K – $2M · Pre-Seed · Seed
→
OT
Olive Tree Ventures
$500K – $1.5M · Series A · Series B
→
Quick Reference
Stages
Pre-Seed · Seed
Decision
Partnership
Warm Intro
Not Required
Involvement
Advisor
Location
Zurich, Switzerland
Sector Focus
Consumer Apps & SocialClimate & SustainabilityHealthcare & Digital Health
Models
Deep TechUniversity Spin-Offs
Technology
AI/MLHardwareBiotech
See all Consumer Apps & Social investors →See all Climate & Sustainability investors →See all Healthcare & Digital Health investors →
Visit www.dart.ventures ↗

See how Dart Ventures matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Consumer Apps & SocialClimate & SustainabilityHealthcare & Digital Health

See how Dart Ventures matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched August 29, 2026F4 Research Engine